Cargando…
Allopurinol-Induced Stevens–Johnson Syndrome (SJS)
Allopurinol is a commonly used medication that lowers uric acid production which is essential for gout treatment and prevention. Although many patients tolerate allopurinol therapy without severe complications; Stevens–Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are life-threatening...
Autores principales: | Anis, Takla R, Meher, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557962/ https://www.ncbi.nlm.nih.gov/pubmed/37811521 http://dx.doi.org/10.2147/CPAA.S427714 |
Ejemplares similares
-
A diagnosis of Stevens-Johnson Syndrome (SJS) in a patient presenting with superficial keratitis
por: Chan, Forson, et al.
Publicado: (2018) -
Stevens–Johnson syndrome–toxic epidermal necrolysis (SJS–TEN) overlap associated with carbamazepine use
por: Suresh Kumar, P.N., et al.
Publicado: (2005) -
Allopurinol: Stevens Johnson syndrome/toxic epidermal necrolysis: case report
Publicado: (2022) -
962 Recurrent Episodes of Stevens Johnson Syndrome (SJS): Clinical and Epidemiologic Characteristics
por: Olson, Daniel, et al.
Publicado: (2014) -
Stevens–Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN): Immunologic Reactions
por: Zimmerman, Danielle, et al.
Publicado: (2019)